Question 1

Does Jacobs Levy Equity Management own AMLX stock?

Accepted Answer

No. Jacobs Levy Equity Management exited its AMLX (Amylyx Pharmaceuticals) position in Q2 2025. Its Q1 2025 13F listed 77,091 shares worth $272,902.

Question 2

How many shares of AMLX does Jacobs Levy Equity Management own?

Accepted Answer

None since Q2 2025, when Jacobs Levy Equity Management exited the position. Its Q1 2025 13F listed 77,091 shares worth $272,902.

Question 3

What is Jacobs Levy Equity Management's AMLX position worth?

Accepted Answer

Jacobs Levy Equity Management's AMLX position was worth $272,902 in its Q1 2025 13F, before the exit in Q2 2025.

Question 4

Is Jacobs Levy Equity Management buying or selling AMLX?

Accepted Answer

In Q2 2025, Jacobs Levy Equity Management exited its entire AMLX position.

Question 5

When did Jacobs Levy Equity Management first buy AMLX?

Accepted Answer

Jacobs Levy Equity Management first reported AMLX in its Q2 2024 13F and listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price
2025-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$6.33
2025-Q1	Decreased	77,091	-75.5%	$272,902	0.0%	$3.66
2024-Q4	Decreased	314,939	-34.2%	$1.2M	0.0%	$3.84
2024-Q3	Decreased	478,440	-18.8%	$1.6M	0.0%	$3.08